Informatie:
Fout:
ID
22448
Beschrijving
Study part: HES History or Prior HES Therapies Screening Visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.
Trefwoorden
Versies (1)
- 04.06.17 04.06.17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
4. Juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
HES History or Prior HES Therapies Screening Visit Mepolizumab HES NCT00086658
HES History or Prior HES Therapies Screening Visit
- StudyEvent: ODM
Similar models
HES History or Prior HES Therapies Screening Visit
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
year of diagnosis Hypereosinophilic Syndrome
Item
Year of diagnosis of HES
partialDate
C0439234 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C1540912 (UMLS CUI [1,3])
C0011900 (UMLS CUI [1,2])
C1540912 (UMLS CUI [1,3])
Therapy HES
Item
Has the subject received any of the below therapies for HES within 5 years prior to the Screening Visit?
boolean
C0087111 (UMLS CUI [1,1])
C1540912 (UMLS CUI [1,2])
C1540912 (UMLS CUI [1,2])
Interferon alpha
Item
Interferon α
boolean
C0002199 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Hydroxyurea
Item
Hydroxyurea
boolean
C0020402 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Cyclosporin
Item
Cyclosporin
boolean
C0010592 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Cyclophosphamide
Item
Cyclophosphomide
boolean
C0010583 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Imatinib Mesylate
Item
Imatinib Mesylate
boolean
C0939537 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Methotrexate
Item
Methotrexate
boolean
C0025677 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Vincristine
Item
Vincristine
boolean
C0042679 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Busulfan
Item
Busulfan
boolean
C0006463 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Chlorambucil
Item
Chlorambucil
boolean
C0008163 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Immunotherapy
Item
Immunotherapy (other monoclonal antibodies or anti-T cell therapies eg., TNF α inhibitors, alefacept)
boolean
C0021083 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Systemic Corticosteroid
Item
Systemic Corticosteroid(s)
boolean
C4039704 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Other
Item
Other (specify):
text
C0205394 (UMLS CUI [1])
Item
Reason for Treatment Discontinuation
text
C0392360 (UMLS CUI [1,1])
C0677162 (UMLS CUI [1,2])
C0677162 (UMLS CUI [1,2])
CL Item
Lack of Efficacy (Lack of Efficacy)
CL Item
Adverse Event (Adverse Event)
CL Item
Treatment Related Toxicity (Treatment Related Toxicity)
CL Item
Unknown (Unknown)
CL Item
Ongoing (Ongoing)
Geen commentaren